MAPT and Alzheimer disease: Emerging lines of evidence suggest the growing importance of mitochondria damage and energy defects in AD pathogenesis [70], and mitochondrial deficit is proposed as a major hallmark of AD pathogenesis besides amyloid and tau pathologies [70].